HumbertoIsidroAguilarMD

Gastroenterology • Shreveport, LA

Advanced Endoscopic Interventional, Hepatology & Liver Transplantation, Inflammatory Bowel Disease

Physician

Join to view full profile

Dr. Aguilar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Aguilar's full profile

Already have an account?

Office
8383 Millicent Way
Ste B
Shreveport, LA 71115
Phone+1 318-631-9121

Fax+1 318-213-6246

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1993 - 1996
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1989 - 1992
Universidad Catolica de Santiago de GuayaquilClass of 1986

Certifications & Licensure

LA State Medical License 1996 - 2025
FL State Medical License 1990 - 1998
IA State Medical License 1994 - 1998
MN State Medical License 1993 - 1996

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Fellow (AGAF) American Gastroenterological Association, 2009
Fellow (FACG) American College of Gastroenterology

Clinical Trials

Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
Completed
Phase 3
A Study of CDPATH™ to Help Manage and Treat Crohn's Disease Start of enrollment: 2021 Jun 25
Active, not recruiting
Phase 4
Roles: Principal Investigator

Publications & Presentations

PubMed

17 citations
Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.
Thomas F Imperiale, Kyle Porter, Julia Zella, Zubin D Gagrat, Marilyn C Olson
The New England Journal of Medicine. 2024-03-14
27 citations
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-bl...
William J Sandborn, Julian Panés, Silvio Danese, Zaineb Sharafali, Azra Hassanali
The Lancet. Gastroenterology & Hepatology. 2023-01-01
8 citations
Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease.
Christopher V. Almario, Lawrence Kogan, Welmoed K. van Deen, Frank I. Scott, Siddharth Singh
The American Journal of Gastroenterology. 2021-11-03

Professional Memberships